NCT01355562 Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer Status WITHDRAWN Phase PHASE2
NCT01351103 A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands Status COMPLETED Phase PHASE1
NCT01350401 Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma Status TERMINATED Phase PHASE1/PHASE2
NCT01341496 Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal Status TERMINATED Phase PHASE1
NCT01336985 Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads Status TERMINATED Phase PHASE1
NCT01336270 Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients Status COMPLETED Phase N/A
NCT01331915 Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients Status UNKNOWN Phase PHASE1/PHASE2
NCT01323517 Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity Status COMPLETED Phase PHASE2
NCT01321437 Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma Status COMPLETED Phase PHASE2
NCT01313429 Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum Status TERMINATED Phase PHASE1
NCT01308762 A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients Status COMPLETED Phase PHASE1
NCT01308294 Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients Status TERMINATED Phase PHASE1/PHASE2
NCT01294735 Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) Status COMPLETED Phase PHASE1
NCT01290536 Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Status COMPLETED Phase PHASE2
NCT01272609 Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel Status TERMINATED Phase PHASE3
NCT01266603 High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI Status COMPLETED Phase PHASE2
NCT01264874 MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients Status TERMINATED Phase PHASE3
NCT01264731 Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma Status COMPLETED Phase PHASE1